APTUK Position Statement for DHSC PGD Update

The Association of Pharmacy Technicians UK (APTUK), as the professional leadership body for pharmacy technicians, welcome the positive outcome of the DHSC consultation supporting the enabling of registered pharmacy technicians to supply and administer medications under patient group directions.

This is a landmark moment for patient care and will ensure pharmacy technicians are able to safely expand access to pharmacy services in a pressured healthcare landscape. During the COVID-19 pandemic it was also evident that pharmacy technicians and their potential were not able to be fully utilised to support delivery of essential frontline pharmacy services, such as vaccination.

To practise using a PGD, healthcare professionals must have completed any training outlined in the PGD and have been deemed competent and authorised by the provider organisation. As registered profession, pharmacy technicians must also uphold pharmacy professional standards stipulated by the regulator the General Pharmaceutical Council, and complete continued professional development relevant for their area of practice and role.

APTUK acknowledge that initially the powers will apply in England, Wales & Scotland only. This is because pharmacy technicians in Northern Ireland are not currently registered, therefore the planned changes will not enable pharmacy technicians in Northern Ireland to use PGDs. APTUK are assured that once pharmacy technicians in Northern Ireland become registered and regulated, further amendments may be made to permit this.

With this announcement, APTUK have also released the first in a series of supportive documents to educate and support pharmacy technicians with their scope of practice with such developments and changes to legislation.

Read the full article here

Latest News

By BOPA Research Committee on 21st November 2024

National survey about the implementation of JDBS/UK chemo board guidelines on the management of glycaemia in people with cancer

National survey about the implementation of JDBS/UK chemo board guidelines on the management of glycaemia in people with cancer. The purpose is to understand some of the enablers and barriers…

Read article
By BOPA Committee on 18th November 2024

ISOPP CAPhO Symposium 2025

ISOPP CAPhO Symposium 2025 (ISOPP CAPhO 2025) is taking place April 3-6 (Symposium) and April 7 (Masterclasses) at the Victoria Conference Centre, Victoria, British Columbia, Canada. The Symposium is hosted…

Read article
By BOPA Education and Training Subcommittee on 18th November 2024

Project to link members to MPharm course in the UK

Dear BOPA Members, The Education & Training subcommittee are working on a project to link BOPA members into every undergraduate MPharm course in the UK, with the aim of providing…

Read article
By EDI Subcommittee on 8th November 2024

BOPA EDI membership survey

We invite you to take part in a quick BOPA EDI membership survey. Your responses will assist the BOPA Equity, Diversity and Inclusion (EDI) subcommittee to better serve the membership…

Read article